{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:01:19Z","timestamp":1767855679053,"version":"3.49.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112396"],"award-info":[{"award-number":["70112396"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In Germany, evidence-based outpatient smoking cessation therapies are widely available. Long-term abstinence rates, however, are limited. Studies suggest that short-term residential therapy enables a higher level of environmental control, more intense contact and greater support among patients and from therapists, which could result in higher abstinence rates. The aim of the current START-study is to investigate the long-term efficacy of a short-term residential therapy exclusively for smoking cessation, conducted by a mobile team of expert therapists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A randomized controlled trial (RCT) is conducted to examine the efficacy of residential behavior therapeutic smoking cessation therapy compared to standard outpatient behavior therapeutic smoking cessation group therapy. Adult smokers consuming 10 or more cigarettes per day, who are willing to stop smoking, are randomized in a ratio of 1:1 between therapy groups. The primary endpoint is sustained abstinence for 6-month and 12-month periods. Secondary endpoints include smoking status after therapy, 7-day point abstinence after the 6-month and 12-month follow-ups, level of physical dependence, cost-effectiveness, use of nicotine replacement products, health-related quality of life, self-efficacy expectation for tobacco abstinence, motivational and volitional determinants of behavior change, self-reported depressive symptom severity, adverse events and possible side effects. Assessments will take place at baseline, post-therapy, and at 6-month and 12-month intervals after smoking cessation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>There is a high demand for long-term effective smoking cessation therapies. This study represents the first prospective RCT to examine the long-term efficacy of a residential smoking cessation therapy program compared to standard outpatient group therapy as an active control condition. The residential therapeutic concept may serve as a new model to substantially enhance future cessation therapies and improve the understanding of therapeutic impact factors on tobacco abstinence. Utilizing a mobile team, the model could be applied efficiently to medical centers that do not have permanent and trained personnel for smoking cessation at their disposal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>German Register for Clinical Trials (Deutsches Register f\u00fcr Klinische Studien),<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00013466\">DRKS00013466<\/jats:ext-link>. Retrospectively registered on 1 April 2019.<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=start\">https:\/\/www.drks.de\/drks_web\/navigate.do?navigationId=start<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13063-020-04253-x","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T10:03:23Z","timestamp":1592906603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy (\u2018START-Study\u2019): study protocol of a randomized controlled trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Jonas","family":"Dickreuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Schmoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"J\u00e4hne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens A.","family":"Leifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"4253_CR1","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"JD Stanaway","year":"2018","unstructured":"Stanaway JD, Afshin A, Gakidou E, Lim SS. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1923\u201394.","journal-title":"Lancet."},{"key":"4253_CR2","first-page":"571","volume":"115","author":"U Mons","year":"2018","unstructured":"Mons U, Gredner T, Behrens G, Stock C, Brenner H. Cancers due to smoking and high alcohol consumption. Dtsch Aerzteblatt Int. 2018;115:571\u20137.","journal-title":"Dtsch Aerzteblatt Int"},{"key":"4253_CR3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.toxrep.2015.07.013","volume":"2","author":"R Kamal","year":"2015","unstructured":"Kamal R, Srivastava AK, Kesavachandran CN. Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers. Toxicol Rep. 2015;2:1064\u201374.","journal-title":"Toxicol Rep"},{"key":"4253_CR4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","volume":"388","author":"GBD 2015 Risk Factors Collaborators","year":"2016","unstructured":"GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659\u2013724.","journal-title":"Lancet"},{"key":"4253_CR5","doi-asserted-by":"crossref","first-page":"j5855","DOI":"10.1136\/bmj.j5855","volume":"360","author":"A Hackshaw","year":"2018","unstructured":"Hackshaw A, Morris JK, Boniface S, Tang J-L, Milenkovi\u0107 D. Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports. BMJ. 2018;360:j5855.","journal-title":"BMJ."},{"key":"4253_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/tobaccocontrol-2016-053305","volume":"27","author":"M Goodchild","year":"2018","unstructured":"Goodchild M, Nargis N, Tursan d\u2019Espaignet E. Global economic cost of smoking-attributable diseases. Tob Control. 2018;27:58\u201364.","journal-title":"Tob Control"},{"key":"4253_CR7","volume-title":"Durch Rauchen und Passivrauchen verursachte Krebserkrankungen","author":"Deutsches Krebsforschungszentrum (ed.)","year":"2008","unstructured":"Deutsches Krebsforschungszentrum (ed.). Durch Rauchen und Passivrauchen verursachte Krebserkrankungen. Heidelberg: Deutsches Krebsforschungszentrum; 2008."},{"key":"4253_CR8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bmj.321.7257.323","volume":"321","author":"R Peto","year":"2000","unstructured":"Peto R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case\u2013control studies. BMJ. 2000;321:323\u20139.","journal-title":"BMJ."},{"key":"4253_CR9","first-page":"1","volume":"7","author":"D Hatzilia","year":"2017","unstructured":"Hatzilia D, Malliarou M, Korompeli A, Tsoumakas K, Fildissis G. Smoking cessation process and quality of life. J Nurs Educ Pract. 2017;7:1\u201312.","journal-title":"J Nurs Educ Pract"},{"key":"4253_CR10","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.15585\/mmwr.mm6552a1","volume":"65","author":"S Babb","year":"2017","unstructured":"Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults \u2014 United States, 2000\u20132015. MMWR Morb Mortal Wkly Rep. 2017;65:1457\u201364.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4253_CR11","first-page":"451","volume":"106","author":"LP Breitling","year":"2009","unstructured":"Breitling LP, Rothenbacher D, Stegmaier C, Raum E, Brenner H. Aufh\u00f6rversuche und -wille bei \u00e4lteren rauchern: Epidemiologische Beitr\u00e4ge zur Diskussion um \u201cLifestyle\u201d versus \u201cSucht\u201d. Dtsch \u00c4rztebl Int. 2009;106:451\u20135.","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"4253_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugalcdep.2006.04.004","volume":"85","author":"JR Hughes","year":"2006","unstructured":"Hughes JR, Helzer JE, Lindberg SA. Prevalence of DSM\/ICD-defined nicotine dependence. Drug Alcohol Depend. 2006;85:91\u2013102.","journal-title":"Drug Alcohol Depend"},{"key":"4253_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","volume":"99","author":"JR Hughes","year":"2004","unstructured":"Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29\u201338.","journal-title":"Addiction"},{"key":"4253_CR14","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1055\/s-0035-1548913","volume":"78","author":"C Kr\u00f6ger","year":"2015","unstructured":"Kr\u00f6ger C, Gomes de Matos E, Piontek D, Wenig JR. Ausstiegsversuche und Hilfsmittelnutzung unter Rauchern in Deutschland: Ergebnisse aus dem Epidemiologischen Suchtsurvey 2012. Gesundheitswesen. 2015;78:752\u20138.","journal-title":"Gesundheitswesen."},{"key":"4253_CR15","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ntr\/nts164","volume":"15","author":"T Raupach","year":"2012","unstructured":"Raupach T, West R, Brown J. The most \u201csuccessful\u201d method for failing to quit smoking is unassisted cessation. Nicotine Tob Res. 2012;15:748\u20139.","journal-title":"Nicotine Tob Res"},{"key":"4253_CR16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1024\/0939-5911\/a000423","volume":"62","author":"A Batra","year":"2016","unstructured":"Batra A, Petersen KU, Hoch E, Andreas S, Bartsch G, Gohlke H, et al. S3 guideline \u201cscreening, diagnostics, and treatment of harmful and addictive tobacco use\u201d: short version. Sucht. 2016;62:139\u201352.","journal-title":"Sucht."},{"key":"4253_CR17","doi-asserted-by":"crossref","unstructured":"Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Tobacco Addiction Group, editor. Cochrane Database Syst Rev. 2016; http:\/\/doi.wiley.com\/10.1002\/14651858.CD008286.pub3.","DOI":"10.1002\/14651858.CD008286.pub3"},{"key":"4253_CR18","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/add.12633","volume":"109","author":"J Hartmann-Boyce","year":"2014","unstructured":"Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T. Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction. 2014;109:1414\u201325.","journal-title":"Addiction."},{"key":"4253_CR19","doi-asserted-by":"crossref","unstructured":"Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017; http:\/\/doi.wiley.com\/10.1002\/14651858.CD001007.pub3.","DOI":"10.1002\/14651858.CD001007.pub3"},{"key":"4253_CR20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/ADM.0000000000000239","volume":"10","author":"JM Williams","year":"2016","unstructured":"Williams JM, Steinberg ML, Kenefake AN, Burke MV. An argument for change in tobacco treatment options guided by the ASAM criteria for patient placement. J Addict Med. 2016;10:291\u20139.","journal-title":"J Addict Med"},{"key":"4253_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4065\/mcp.2010.0703","volume":"86","author":"JT Hays","year":"2011","unstructured":"Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, et al. Residential treatment compared with outpatient treatment for tobacco use and dependence. Mayo Clin Proc. 2011;86:203\u20139.","journal-title":"Mayo Clin Proc"},{"key":"4253_CR22","doi-asserted-by":"crossref","first-page":"u204964.w2110","DOI":"10.1136\/bmjquality.u204964.w2110","volume":"3","author":"G Bickerstaffe","year":"2014","unstructured":"Bickerstaffe G. Smoking cessation for hospital inpatients. BMJ Qual Improv Rep. 2014;3:u204964.w2110.","journal-title":"BMJ Qual Improv Rep"},{"key":"4253_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jsat.2008.06.005","volume":"36","author":"SG Ferguson","year":"2009","unstructured":"Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abus Treat. 2009;36:235\u201343.","journal-title":"J Subst Abus Treat"},{"key":"4253_CR24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuroimage.2016.03.015","volume":"151","author":"SL Zelle","year":"2017","unstructured":"Zelle SL, Gates KM, Fiez JA, Sayette MA, Wilson SJ. The first day is always the hardest: functional connectivity during cue exposure and the ability to resist smoking in the initial hours of a quit attempt. NeuroImage. 2017;151:24\u201332.","journal-title":"NeuroImage."},{"key":"4253_CR25","first-page":"1217","volume":"53","author":"2008 PHS Guideline Update Panel, Liaisons, and Staff","year":"2008","unstructured":"2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008;53:1217\u201322.","journal-title":"Respir Care"},{"key":"4253_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.arbres.2016.11.004","volume":"53","author":"CA Jim\u00e9nez Ruiz","year":"2017","unstructured":"Jim\u00e9nez Ruiz CA, de Granda Orive JI, Solano Reina S, Riesco Miranda JA, de Higes ME, Pascual Lled\u00f3 JF, et al. Guidelines for the treatment of smoking in hospitalized patients. Arch Bronconeumol Engl Ed. 2017;53:387\u201394.","journal-title":"Arch Bronconeumol Engl Ed"},{"key":"4253_CR27","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1360-0443.2009.02605.x","volume":"104","author":"M Ussher","year":"2009","unstructured":"Ussher M, Cropley M, Playle S, Mohidin R, West R. Effect of isometric exercise and body scanning on cigarette cravings and withdrawal symptoms. Addict Abingdon Engl. 2009;104:1251\u20137.","journal-title":"Addict Abingdon Engl"},{"key":"4253_CR28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/ntr\/ntr011","volume":"13","author":"M Kotlyar","year":"2011","unstructured":"Kotlyar M, Drone D, Thuras P, Hatsukami DK, Brauer L, Adson DE, et al. Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers. Nicotine Tob Res. 2011;13:492\u20137.","journal-title":"Nicotine Tob Res"},{"key":"4253_CR29","doi-asserted-by":"crossref","unstructured":"Ussher MH, Taylor AH, Faulkner GEJ. Exercise interventions for smoking cessation. Cochrane Database Syst Rev. 2014; http:\/\/doi.wiley.com\/10.1002\/14651858.CD002295.pub5.","DOI":"10.1002\/14651858.CD002295.pub5"},{"key":"4253_CR30","volume-title":"Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline","author":"MC Fiore","year":"2008","unstructured":"Fiore MC, Ja\u00e9n CR, Baker TB, Bailey WC, Benowitz NL, Curry SL, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville: U.S. Department of Health and Human Services. Public Health Service; 2008."},{"key":"4253_CR31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/inr.12320","volume":"64","author":"Z Kazemzadeh","year":"2017","unstructured":"Kazemzadeh Z, Manzari ZS, Pouresmail Z. Nursing interventions for smoking cessation in hospitalized patients: a systematic review. Int Nurs Rev. 2017;64:263\u201375.","journal-title":"Int Nurs Rev"},{"key":"4253_CR32","doi-asserted-by":"crossref","unstructured":"Rigotti NA, Clair C, Munaf\u00f2 MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Tobacco Addiction Group, editor. Cochrane Database Syst Rev. 2012; Available from: http:\/\/doi.wiley.com\/10.1002\/14651858.CD001837.pub3. Cited 26 Jul 2019.","DOI":"10.1002\/14651858.CD001837.pub3"},{"key":"4253_CR33","doi-asserted-by":"crossref","first-page":"e1285","DOI":"10.4088\/JCP.14m09016","volume":"76","author":"PG Barnett","year":"2015","unstructured":"Barnett PG, Wong W, Jeffers A, Hall SM, Prochaska JJ. Cost-effectiveness of smoking cessation treatment initiated during psychiatric hospitalization: analysis from a randomized controlled trial. J Clin Psychiatry. 2015;76:e1285\u201391.","journal-title":"J Clin Psychiatry"},{"key":"4253_CR34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/pmed.2000.0824","volume":"32","author":"EK France","year":"2001","unstructured":"France EK, Glasgow RE, Marcus AC. Smoking cessation interventions among hospitalized patients: what have we learned? Prev Med. 2001;32:376\u201388.","journal-title":"Prev Med"},{"key":"4253_CR35","doi-asserted-by":"crossref","unstructured":"Ward CE, Hall SV, Barnett PG, Jordan N, Duffy SA. Cost-effectiveness of a nurse-delivered, inpatient smoking cessation intervention. Transl Behav Med. 2019; https:\/\/academic.oup.com\/tbm\/advance-article\/doi\/10.1093\/tbm\/ibz101\/5522031.","DOI":"10.1093\/tbm\/ibz101"},{"key":"4253_CR36","doi-asserted-by":"crossref","DOI":"10.17433\/978-3-17-026572-1","volume-title":"Tabakentw\u00f6hnung. Ein Leitfaden f\u00fcr Therapeuten. 1. Aufl","author":"A Batra","year":"2004","unstructured":"Batra A, Buchkremer G. Tabakentw\u00f6hnung. Ein Leitfaden f\u00fcr Therapeuten. 1. Aufl. Stuttgart: Kohlhammer; 2004."},{"key":"4253_CR37","volume-title":"Das Rauchfrei Programm \u2013 Jahresbericht 2018 \u2013 Berichtszeitraum 01.01.2017\u201331.12.2017","author":"C Kr\u00f6ger","year":"2018","unstructured":"Kr\u00f6ger C, Gr\u00f6ll J. Das Rauchfrei Programm \u2013 Jahresbericht 2018 \u2013 Berichtszeitraum 01.01.2017\u201331.12.2017. M\u00fcnchen: IFT-Gesundheitsf\u00f6rderung; 2018."},{"key":"4253_CR38","first-page":"124","volume":"76","author":"JT Hays","year":"2001","unstructured":"Hays JT, Wolter TD, Eberman KM, Croghan IT, Offord KP, Hurt RD. Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clin Proc. 2001;76:124\u201333.","journal-title":"Mayo Clin Proc"},{"key":"4253_CR39","doi-asserted-by":"crossref","unstructured":"Ho R, Fok P, Chan H. Pilot study of a 3-day residential treatment for smoking cessation in Hong Kong. Tob Prev Cessat. 2018;4 Available from: http:\/\/www.journalssystem.com\/tpc\/Pilot-study-of-a-3-day-residential-treatment-for-smoking-cessation-in-Hong-Kong,101577,0,2.html. Cited 26 Jul 2019.","DOI":"10.18332\/tpc\/101577"},{"key":"4253_CR40","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.mayocp.2013.05.027","volume":"88","author":"JE Hodgkin","year":"2013","unstructured":"Hodgkin JE, Sachs DPL, Swan GE, Jack LM, Titus BL, Waldron SJS, et al. Outcomes from a patient-centered residential treatment plan for tobacco dependence. Mayo Clin Proc. 2013;88:970\u20136.","journal-title":"Mayo Clin Proc"},{"key":"4253_CR41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2466\/pr0.2001.89.1.99","volume":"89","author":"EH Hoffman","year":"2001","unstructured":"Hoffman EH, Blackburn C, Cullari S. Brief residential treatment for nicotine addiction: a five-year follow-up study. Psychol Rep. 2001;89:99\u2013105.","journal-title":"Psychol Rep"},{"key":"4253_CR42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.puhe.2015.02.011","volume":"129","author":"R Schoberberger","year":"2015","unstructured":"Schoberberger R, B\u00f6hm G, Schroeder Y. Heavy dependent nicotine smokers \u2013 newfound lifestyle appreciation after quitting successfully. Experiences from inpatient smoking cessation therapy. Public Health. 2015;129:539\u201344.","journal-title":"Public Health"},{"key":"4253_CR43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1024\/suc.2000.46.6.424","volume":"46","author":"R Schoberberger","year":"2000","unstructured":"Schoberberger R, Bayer P, Groman E, Kunze M. Station\u00e4re Rauchertherapie \u2013 Projekt Josefhof. Erste Resultate des Modellprojekts. Sucht Z F\u00fcr Wiss Prax. 2000;46:424\u20137.","journal-title":"Sucht Z F\u00fcr Wiss Prax"},{"key":"4253_CR44","first-page":"299","volume":"20","author":"JA Leifert","year":"2018","unstructured":"Leifert JA, Engler U, Pschicholz B, Schulz C, J\u00e4hne A. Station\u00e4re Behandlung ausschlie\u00dflich zur Raucherentw\u00f6hnung\u2014Ergebnisse einer Pilotstudie. Suchtmedizin. 2018;20:299\u2013304.","journal-title":"Suchtmedizin."},{"key":"4253_CR45","volume-title":"Empfehlungen des wissenschaftlichen Kuratoriums der DHS zu Grenzwerten f\u00fcr den Konsum alkoholischer Getr\u00e4nke","author":"H Seitz","year":"2010","unstructured":"Seitz H, B\u00fchringer G. Empfehlungen des wissenschaftlichen Kuratoriums der DHS zu Grenzwerten f\u00fcr den Konsum alkoholischer Getr\u00e4nke. Hamm: Deutsche Hauptstelle f\u00fcr Suchtfragen; 2010."},{"key":"4253_CR46","volume-title":"Motivational interviewing. 3. Auflage des Standardwerks in Deutsch","author":"WR Miller","year":"2015","unstructured":"Miller WR, Rollnick S, Demmel R. Motivational interviewing. 3. Auflage des Standardwerks in Deutsch. Freiburg im Breisgau: Lambertus; 2015."},{"key":"4253_CR47","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurheartj\/ehn552","volume":"30","author":"S Mottillo","year":"2009","unstructured":"Mottillo S, Filion KB, B\u00e9lisle P, Joseph L, Gervais A, O\u2019Loughlin J, et al. Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:718\u201330.","journal-title":"Eur Heart J"},{"key":"4253_CR48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1027\/1016-9040.13.2.141","volume":"13","author":"R Schwarzer","year":"2008","unstructured":"Schwarzer R, Luszczynska A. How to overcome health-compromising behaviors: the Health Action Process Approach. Eur Psychol. 2008;13:141\u201351.","journal-title":"Eur Psychol"},{"key":"4253_CR49","unstructured":"Hoffmeyer-Zlotnik JHP, Glemser A, Heckel C, von der Heyde C, Quitt H, Deutschland, editors. Demographische standards: eine gemeinsame Empfehlung des ADM Arbeitskreis Deutscher Markt- und Sozialforschungsinstitute e.V., der Arbeitsgemeinschaft Sozialwissenschaftlicher Institute e.V. (ASI) und des Statistischen Bundesamtes. 5., \u00fcberarb. und erw. Aufl. Wiesbaden: Statistisches Bundesamt; 2010."},{"key":"4253_CR50","volume-title":"FTNA. Fagerstr\u00f6m-Test f\u00fcr Nikotinabh\u00e4ngigkeit","author":"S Bleich","year":"2002","unstructured":"Bleich S, Havemann-Reinecke U, Kornhuber J. FTNA. Fagerstr\u00f6m-Test f\u00fcr Nikotinabh\u00e4ngigkeit. G\u00f6ttingen: Beltz; 2002."},{"key":"4253_CR51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1026\/\/0012-1924.45.3.138","volume":"45","author":"C J\u00e4kle","year":"1999","unstructured":"J\u00e4kle C, Keller S, Baum E, Basler H-D. Skalen zur Selbstwirksamkeit und Entscheidungsbalance im Proze\u00df der Verhaltens\u00e4nderung von Rauchern. Diagnostica. 1999;45:138\u201346.","journal-title":"Diagnostica."},{"key":"4253_CR52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/08870446.2011.603422","volume":"27","author":"T Radtke","year":"2012","unstructured":"Radtke T, Scholz U, Keller R, Hornung R. Smoking is ok as long as I eat healthily: compensatory health beliefs and their role for intentions and smoking within the Health Action Process Approach. Psychol Health. 2012;27:91\u2013107.","journal-title":"Psychol Health"},{"key":"4253_CR53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/08870440801902519","volume":"24","author":"U Scholz","year":"2009","unstructured":"Scholz U, Nagy G, G\u00f6hner W, Luszczynska A, Kliegel M. Changes in self-regulatory cognitions as predictors of changes in smoking and nutrition behaviour. Psychol Health. 2009;24:545\u201361.","journal-title":"Psychol Health"},{"key":"4253_CR54","volume-title":"Gesundheitsfragebogen f\u00fcr Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Frageb\u00f6gen, Schablonen. 2. Auflage","author":"B L\u00f6we","year":"2002","unstructured":"L\u00f6we B, Spitzer RL, Zipfel S, Herzog W. Gesundheitsfragebogen f\u00fcr Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Frageb\u00f6gen, Schablonen. 2. Auflage. Karlsruhe: Pfizer; 2002."},{"key":"4253_CR55","volume-title":"EQ-5D-5L User Guide","author":"EuroQol Research Foundation","year":"2019","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide. 2019. https:\/\/euroqol.org\/publications\/user-guides. Accessed 10 Dec 2019."},{"key":"4253_CR56","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","volume":"100","author":"R West","year":"2005","unstructured":"West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100:299\u2013303.","journal-title":"Addiction"},{"key":"4253_CR57","volume-title":"Benefits and risks of smoking cessation","author":"NA Rigotti","year":"2019","unstructured":"Rigotti NA. Benefits and risks of smoking cessation. 2019. https:\/\/www.uptodate.com\/contents\/benefits-and-risks-of-smoking-cessation. Accessed 10 May 2019."},{"key":"4253_CR58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1617-9625-8-8","volume":"8","author":"EJ Mills","year":"2010","unstructured":"Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis. 2010;8:8.","journal-title":"Tob Induc Dis"},{"key":"4253_CR59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa1808779","volume":"380","author":"P Hajek","year":"2019","unstructured":"Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380:629\u201337.","journal-title":"N Engl J Med"},{"key":"4253_CR60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1037\/a0024451","volume":"121","author":"TR Kirchner","year":"2012","unstructured":"Kirchner TR, Shiffman S, Wileyto EP. Relapse dynamics during smoking cessation: recurrent abstinence violation effects and lapse-relapse progression. J Abnorm Psychol. 2012;121:187\u201397.","journal-title":"J Abnorm Psychol"},{"key":"4253_CR61","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/add.13913","volume":"112","author":"TS Scheuermann","year":"2017","unstructured":"Scheuermann TS, Richter KP, Rigotti NA, Cummins SE, Harrington KF, Sherman SE, et al. Accuracy of self-reported smoking abstinence in clinical trials of hospital-initiated smoking interventions. Addiction. 2017;112:2227\u201336.","journal-title":"Addiction."},{"key":"4253_CR62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/tobaccocontrol-2011-050298","volume":"22","author":"E Avila-Tang","year":"2013","unstructured":"Avila-Tang E, Al-Delaimy WK, Ashley DL, Benowitz N, Bernert JT, Kim S, et al. Assessing secondhand smoke using biological markers. Tob Control. 2013;22:164\u201371.","journal-title":"Tob Control"},{"key":"4253_CR63","first-page":"ZE04","volume":"10","author":"M Raja","year":"2016","unstructured":"Raja M, Garg A, Yadav PK, Jha K, Handa S. Diagnostic methods for detection of cotinine level in tobacco users: a review. J Clin Diagn Res. 2016;10:ZE04\u20136.","journal-title":"J Clin Diagn Res"},{"key":"4253_CR64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/13547500701421341","volume":"12","author":"W Zieli\u0144ska-Danch","year":"2007","unstructured":"Zieli\u0144ska-Danch W, Wardas W, Sobczak A, Szo\u0142tysek-Bo\u0142dys I. Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers. 2007;12:484\u201396.","journal-title":"Biomarkers."},{"key":"4253_CR65","first-page":"4","volume":"43","author":"PE Schupp","year":"1997","unstructured":"Schupp PE, Batra A, Buchkremer G. Rauchanamnese zur Pr\u00e4diktion des Abstinenzerfolges bei Rauchern. Sucht. 1997;43:4\u201310.","journal-title":"Sucht."},{"key":"4253_CR66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1911614","volume":"382","author":"JE Layden","year":"2020","unstructured":"Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin \u2014 final report. N Engl J Med. 2020;382:903\u201316.","journal-title":"N Engl J Med"},{"key":"4253_CR67","volume-title":"Public health consequences of e-cigarettes","author":"National Academies of Sciences, Engineering, and Medicine","year":"2018","unstructured":"National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press; 2018."},{"key":"4253_CR68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0306-4603(90)90070-E","volume":"15","author":"WF Velicer","year":"1990","unstructured":"Velicer WF, Di Clemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15:271\u201383.","journal-title":"Addict Behav"},{"key":"4253_CR69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future. Appl Health Econ Health Policy. 2017;15:127\u201337.","journal-title":"Appl Health Econ Health Policy"},{"key":"4253_CR70","doi-asserted-by":"crossref","first-page":"e007249","DOI":"10.1136\/bmjopen-2014-007249","volume":"5","author":"P-C Chen","year":"2015","unstructured":"Chen P-C, Kuo RN-C, Lai C-K, Tsai S-T, Lee Y-C. The relationship between smoking status and health-related quality of life among smokers who participated in a 1-year smoking cessation programme in Taiwan: a cohort study using the EQ-5D. BMJ Open. 2015;5:e007249.","journal-title":"BMJ Open"},{"key":"4253_CR71","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/jech-2012-201019","volume":"67","author":"H Maheswaran","year":"2013","unstructured":"Maheswaran H, Petrou S, Rees K, Stranges S. Estimating EQ-5D utility values for major health behavioural risk factors in England. J Epidemiol Community Health. 2013;67:172\u201380.","journal-title":"J Epidemiol Community Health"},{"key":"4253_CR72","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","volume":"12","author":"MC Weinstein","year":"2009","unstructured":"Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009;12:S5\u20139.","journal-title":"Value Health"},{"key":"4253_CR73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","volume":"96","author":"SJ Whitehead","year":"2010","unstructured":"Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5\u201321.","journal-title":"Br Med Bull"},{"key":"4253_CR74","volume-title":"Incremental cost-effectiveness ratio (ICER)","author":"York Health Economics Consortium","year":"2016","unstructured":"York Health Economics Consortium. Incremental cost-effectiveness ratio (ICER). York: York Health Econ. Consort; 2016. https:\/\/www.yhec.co.uk\/glossary\/incremental-cost-effectiveness-ratio-icer\/. Accessed 26 Jul 2019."},{"key":"4253_CR75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2217\/cer.15.38","volume":"4","author":"R Schwarzer","year":"2015","unstructured":"Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, et al. Systematic overview of cost-effectiveness thresholds in ten countries across four continents. J Comp Eff Res. 2015;4:485\u2013504.","journal-title":"J Comp Eff Res"},{"key":"4253_CR76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1300\/J069v27n01_08","volume":"27","author":"SC Ames","year":"2008","unstructured":"Ames SC, Croghan IT, Clark MM, Patten CA, Stevens SR, Schroeder DR, et al. Change in perceived stress, partner support, decisional balance, and self-efficacy following residential nicotine dependence treatment. J Addict Dis. 2008;27:73\u201382.","journal-title":"J Addict Dis"},{"key":"4253_CR77","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ntr\/ntq050","volume":"12","author":"R Borland","year":"2010","unstructured":"Borland R, Yong H-H, Balmford J, Cooper J, Cummings KM, O\u2019Connor RJ, et al. Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine Tob Res. 2010;12:S4\u201311.","journal-title":"Nicotine Tob Res"},{"key":"4253_CR78","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1146\/annurev-clinpsy-050212-185602","volume":"9","author":"TR Schlam","year":"2013","unstructured":"Schlam TR, Baker TB. Interventions for tobacco smoking. Annu Rev Clin Psychol. 2013;9:675\u2013702.","journal-title":"Annu Rev Clin Psychol"},{"key":"4253_CR79","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ejsp.258","volume":"35","author":"FF Sniehotta","year":"2005","unstructured":"Sniehotta FF, Schwarzer R, Scholz U, Sch\u00fcz B. Action planning and coping planning for long-term lifestyle change: theory and assessment. Eur J Soc Psychol. 2005;35:565\u201376.","journal-title":"Eur J Soc Psychol"},{"key":"4253_CR80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1026\/0012-1924.50.4.171","volume":"50","author":"K Gr\u00e4fe","year":"2004","unstructured":"Gr\u00e4fe K, Zipfel S, Herzog W, L\u00f6we B. Screening psychischer St\u00f6rungen mit dem \u201cGesundheitsfragebogen f\u00fcr Patienten (PHQ-D)\u201d. Diagnostica. 2004;50:171\u201381.","journal-title":"Diagnostica."},{"key":"4253_CR81","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"4253_CR82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3928\/0048-5713-20020901-06","volume":"32","author":"K Kroenke","year":"2002","unstructured":"Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:509\u201315.","journal-title":"Psychiatr Ann"},{"key":"4253_CR83","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1037\/0278-6133.7.6.545","volume":"7","author":"SJ Curry","year":"1988","unstructured":"Curry SJ, Marlatt GA, Gordon J, Baer JS. A comparison of alternative theoretical approaches to smoking cessation and relapse. Health Psychol. 1988;7:545\u201356.","journal-title":"Health Psychol"},{"key":"4253_CR84","first-page":"473","volume":"23","author":"VH Rice","year":"1994","unstructured":"Rice VH, Fox DH, Lepczyk M, Sieggreen M, Mullin M, Jarosz P, et al. A comparison of nursing interventions for smoking cessation in adults with cardiovascular health problems. Heart Lung. 1994;23:473\u201386.","journal-title":"Heart Lung"},{"key":"4253_CR85","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0005-7967(83)90011-6","volume":"21","author":"JA Cottraux","year":"1983","unstructured":"Cottraux JA, Harf R, Biossel J-P, Schbath J, Bouvard M, Gillet J. Smoking cessation with behaviour therapy of acupuncture \u2013 a controlled study. Behav Res Ther. 1983;21:417\u201324.","journal-title":"Behav Res Ther"},{"key":"4253_CR86","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2105\/AJPH.80.5.554","volume":"80","author":"HA Lando","year":"1990","unstructured":"Lando HA, McGovern PG, Barrios FX, Etringer BD. Comparative evaluation of American Cancer Society and American Lung Association smoking cessation clinics. Am J Public Health. 1990;80:554\u20139.","journal-title":"Am J Public Health"},{"key":"4253_CR87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-118-7-199304010-00006","volume":"118","author":"JF Hollis","year":"1993","unstructured":"Hollis JF. Nurse-assisted counseling for smokers in primary care. Ann Intern Med. 1993;118:521.","journal-title":"Ann Intern Med"},{"key":"4253_CR88","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archpsyc.59.10.930","volume":"59","author":"SM Hall","year":"2002","unstructured":"Hall SM, Humfleet GL, Reus VI, Mu\u00f1oz RF, Hartz DT, Maude-Griffin R. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry. 2002;59:930.","journal-title":"Arch Gen Psychiatry"},{"key":"4253_CR89","doi-asserted-by":"crossref","DOI":"10.1002\/9783527679188","volume-title":"Sicherung guter wissenschaftlicher Praxis","author":"Deutsche Forschungsgemeinschaft DFG (ed.)","year":"2013","unstructured":"Deutsche Forschungsgemeinschaft DFG (ed.). Sicherung guter wissenschaftlicher Praxis. Weinheim: Wiley-VCH; 2013."},{"key":"4253_CR90","first-page":"313","volume":"13","author":"N Babhadiashar","year":"2014","unstructured":"Babhadiashar N, Sotoudeh M, Azizi E, Bashiri J, Didevar R, Malekzadeh R, et al. Correlation between cigarette smoking and urine cotinine level in gastric cancer patients. Iran J Pharm Res IJPR. 2014;13:313\u20138.","journal-title":"Iran J Pharm Res IJPR"},{"key":"4253_CR91","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/ijerph13121236","volume":"13","author":"S Kim","year":"2016","unstructured":"Kim S. Overview of cotinine cutoff values for smoking status classification. Int J Environ Res Public Health. 2016;13:1236.","journal-title":"Int J Environ Res Public Health"},{"key":"4253_CR92","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1024\/1661-8157\/a003026","volume":"107","author":"D Gruber","year":"2018","unstructured":"Gruber D, Schuurmans MM. Biomarker f\u00fcr Rauchen \u2013 Welche Cut-off-Werte sind anwendbar? Praxis. 2018;107:758\u201362.","journal-title":"Praxis."},{"key":"4253_CR93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ntr\/ntn010","volume":"11","author":"SC Gorber","year":"2009","unstructured":"Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11:12\u201324.","journal-title":"Nicotine Tob Res"},{"key":"4253_CR94","doi-asserted-by":"crossref","DOI":"10.1002\/9781119942283","volume-title":"Multiple imputation and its application","author":"JR Carpenter","year":"2013","unstructured":"Carpenter JR, Kenward MG. Multiple imputation and its application. 1st ed. Chichester: Wiley; 2013.","edition":"1"},{"key":"4253_CR95","volume-title":"WMA Declaration of Helsinki \u2013 ethical principles for medical research involving human subjects","author":"World Medical Association","year":"2018","unstructured":"World Medical Association. WMA Declaration of Helsinki \u2013 ethical principles for medical research involving human subjects. Helsinki: WMA General Assembly; 2018."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-020-04253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-04253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T20:33:23Z","timestamp":1696278803000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-04253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4253"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-04253-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"15 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the regional regulatory ethics committees (Ethics Commission of the Albert-Ludwigs-University Freiburg, Germany; study reference number EK-Freiburg 583\/17). It has been registered at the German Register for clinical trials (DRKS00013466), a primary register of the WHO, and is conducted in accordance with the Declaration of Helsinki on ethical principles for medical research involving human subjects []. Study participation is voluntary and each participant will be comprehensively informed about the objectives of the study and the privacy policy as well as the opportunity to withdraw from the study at any time without stating a reason. Investigators will, separately, collect written informed consent and a privacy statement from each participant. Each participant will receive a copy of the informed consent forms. Data management, monitoring and reporting of the study will be performed in accordance with the <i>Guidelines for Safeguarding Good Scientific Practice<\/i> [].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Participant consent information is available from the corresponding author on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Funding sources: JL has received research funding from German Cancer Aid and the German M. Crohn\/Colitis Association. AJ has received research funding from German Cancer Aid, the German Ministry of Labor, Health and Social System, Family, Women, and Senior Citizens of the State of Baden-W\u00fcrttemberg, as well as Johnson & Johnson.Employment\/membership: JL has received research funding and speakers\u2019 fees from Pfizer Inc. AJ received counselling fees from Pfizer Inc. and Johnson & Johnson, financial support for talks and workshops from Sanofi, Daiichi Sankyo, Bristol-Myers Squibb, Chiesi and Medical Tribune, as well as from medical training institutes and Education Centres (Volkshochschulen). AJ is member of the AWMF-treatment guideline committee for tobacco dependence.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"562"}}